BioCryst Pharmaceuticals
BCRX
BCRX
103 hedge funds and large institutions have $248M invested in BioCryst Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 29
6% less call options, than puts
Call options by funds: $5.36M | Put options by funds: $5.71M
Holders
103
Holding in Top 10
3
Calls
$5.36M
Puts
$5.71M
Top Buyers
| 1 | +$19.4M | |
| 2 | +$8.68M | |
| 3 | +$6.08M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.27M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.44M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$1.22M | |
| 3 | -$1.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$727K |
| 5 |
SIM
Spark Investment Management
New York
|
-$516K |